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developed theory-based models. The use of structural equation modeling in the analysis of intracellular signals is not new. [14] [15] [16] [17] methods
Animals and experimental procedures
Mus musculus C3HeB/FeJ (n = 8) aged 5-8 weeks were infected with 100 µl intratracheal (10 5 CFU/ml) and divided randomly into four groups. The 1 st group (G1) was the group to examine the success of intratracheal infection. The mice in group 1 were euthanized 2-week postinfection and observed whether they have pulmonary TB. (G2) was the group of TB mice without therapy. (G3) was the group of mice with the 2 nd -line anti-TB therapy recommended by the Indonesian National Tuberculosis Control Program. (G4) was the group of mice which was not only treated with the 2 nd -line anti-TB therapy but also received daily oral Vitamin D3 supplementation for 6 months.
Kanamycin (Sigma K1876) was injected im 150 mg/kg body weight once a day in 5 days/week. Pyrazinamide (Sigma P7136) 150 mg/kg body weight, levofloxacin (Sigma 28266) 200 mg/kg body weight, ethionamide (Sigma E6005-5G) 50 mg/kg body weight, cycloserine (Sigma 30020-1G) 300 mg/kg body weight, and Vitamin D3 (Dvion Drops, Merck) 1.25 IU/g body weight were given per intragastric tube once a day in 7 days/week. At the end of treatment, the mice were euthanized. The left lung tissue was processed for immunohistochemistry and the number of bacteria was obtained from the right lung tissue culture.
Immunohistochemistry
The used primary antibody included: anti-Vitamin D receptor antibody (ab3508, abcam), anti-cathelicidin antibody (ab64892 abcam), anti-LC3B antibody (ab63817, abcam), anti-MMP1 antibody (ab137332, abcam), anti-caspase3 (P17) (PA1961-1, BosterBio), and anti-RIPK3 (PA2242, BosterBio). The five different fields per section were analyzed by two independent investigators using the light microscope Olympus BX51 magnification 400x.
Statistical analysis
The statistical analysis was performed by using IBM SPSS 20.0 for Windows. The normality test was done using Shapiro-Wilk. The different test among different groups was analyzed using the one-way ANOVA test or the Kruskal-Wallis test, followed by a post hoc test either with the Tukey's test or the Mann-Whitney test. The two-sided P < 0.05 were considered to indicate a statistically significant result.
Assessing the relationship among variables and predicting the theory-based structural model were done by applying the structural equation modeling test using the smartpls-3.2.6 GmbH
Results

Supplementation of Vitamin D3 in the 2 nd -line anti-tuberculosis increases the VDR expression
Vitamin D is metabolized to 1,25-dihydroxyvitamin D. The hormonal form is the ligand for the Vitamin D receptor. Nuclear receptor-regulated transcription is cell specific. It is necessary to understand aspects of Vitamin D mechanisms of action to facilitate tissue-specific clinical application. Figure 1 visualizes Vitamin D3 receptor expression in lung tissue. Figure 2 shows supplementation of Vitamin D in the 2 nd -line anti-TB which increases the Vitamin D3 receptor expression. M. tuberculosis can infect macrophages and alveolar epithelial type II pneumocytes. [18] Supplementation of Vitamin D3 promoted upregulation of Vitamin D-regulatory protein in infected cells.
Cotreatment of Vitamin D3 and 2 nd -line anti-tuberculosis drugs could enhance cathelin-related antimicrobial peptide and LC3B expression
Vitamin D may reduce the risk of infection through multiple mechanisms. With a Vitamin D response element within its promoter sequence, CRAMP further is a target gene of Vitamin D. Figure 3 shows immunohistochemical analysis of CRAMP in lung tissue. Immunohistochemistry is a technique for investigating protein expression and localization within tissues. Supplementation of Vitamin D increases the antimicrobial protein cathelicidin which is accordance with previous research [ Figure 4 ]. [19] [20] [21] LC3 is an autophagy membrane precursor which is expressed into three variants/posttranslational isoforms of LC3A, LC3B, and LC3C. With lipidation, the posttranslation of LC3B transforms into an 18 kDa LC3I cytosolic form and moves into a 16 kDa LC3II membrane form. Provision of Vitamin D3 increases the conversion of LC3B-I to LC3B-II. [22] Figure 5 shows LC3B expression in lung tissue during M. tuberculosis infection. Figure 6 shows changes in LC3B expression following D3 administration. The expression of LC3B is higher among Vitamin D3-supplemented group. 
Supplementation of Vitamin D3 in the 2 nd -line anti-tuberculosis increases apoptosis
An apoptotic index is the number of positive caspase-3 cells in the cytosol per view field. Figure 7 shows that granulomas are dynamic lesions, both apoptosis and nonapoptosis macrophages are observed. Exogenous tumor necrosis factor (TNF) have been reported to elevate M. tuberculosis-mediated macrophage apoptosis. [23] Figure 8 shows Vitamin D3 induces caspase-3. This study demonstrates that exogenous Vitamin D upregulates caspase-mediated apoptosis. Apoptosis is a mechanism of infected cells to eliminate bacteria. It is the programmed cell death without causing an inflammatory reaction. Vitamin D has a beneficial role in the treatment of TB. Figure 9 shows the mean bacterial count of the D3 supplemented group and the control group. Here, we show that Vitamin D3 have a positive impact on reducing bacterial load. The researcher noted that Vitamin D may help both innate and adaptive immunity. Figure 10 shows immunohistochemical detection of MMP1 in lung tissue. The pulmonary tissue damage involves many factors. The study concludes that supplementation of Vitamin D decreases the expression of MMP1 [ Figure 11 ], a collagenase enzyme that degrades types I, II, and III collagen. These data confirmed that Vitamin D regulate MMP1 expression in tissue where Vitamin D3 receptors are expressed.
Supplementation of Vitamin D3 enhances the effectiveness of 2 nd -line anti-tuberculosis therapy by lowering the number of bacteria, expression of pulmonary collagenase enzyme matrix metalloproteinase-1, and cell necrosis
The increased effectiveness of 2 nd -line anti-TB was also measured by the decreasing the number of cell necrosis which causes bacteria to spread [ Figure 12 ]. Necrosis is an inflammatory form of cell death. RIPK3 facilitates inflammation through damage-associated molecular patterns as well as nuclear factor-kappa B and result in the transcription of inflammatory cytokines. Figure 13 shows RIPK3 expression in response to D3 supplementation. Vitamin D as immunomodulator and-anti-inflammatory agent mitigate cell stress. A comprehensive analysis with structural equation modeling concludes that supplementation of Vitamin D reduces cellular necrosis [Figures 14] . Autophagy reduce necrosis (RIPK3) by decreasing the pulmonary collagenase MMP1 with an indirect effect of −0.543. Autophagy has a protective effect on MMP-mediated cell injury. [24] Apoptosis lowers RIPK3 by decreasing the number of bacteria with indirect effects of-0.544. Necrosis occurs when there is a high-intracellular bacillary load. [25] Apoptosis has control over the number of bacteria that is directly related to necrosis reduction.
dIscussIon
There has been a lot of literature showing the association of TB with Vitamin D deficiency. [26] [27] [28] [29] It is proposed that the lower level result from chronic infection. Calcitriol, which is also referred as the Vitamin D-active form, binds to the Vitamin D3 receptor in the transcription process. The vitamin D receptor is important for adequate immune function. Intervention using a daily and constant dosage of vitamin D3 for 6 months might be appropriate to improve the effectiveness of 2nd-line anti-TB drug therapy. Our study shows that Vitamin D supplementation upregulates VDR expression. has 3 Vitamin D response element. [30] [31] [32] This study shows that oral supplementation with Vitamin D effectively increases cathelicidin expression in the lung. In conclusion, activation of Vitamin D receptor results in the expression of cathelicidin at both mRNA and protein level. Cathelicidin also requires Vitamin D (the Ca2 + mobilizing agent) to reach the target antigen. This protein goes into autofagosom with the help of Ca2 + /calmodulin-dependent kinase (CaMKK)-β. [33, 34] Autophagy involves many factors. During autophagy, damages organelles or intracellular bacteria, is encapsulated in double-membrane autophagosome. The delivery of ubiquitin and antimicrobial peptide to the vesicles important in innate immunity. Colocalization LC3 with phagosome leads to the delivery of immature phagosome to lysosomes. [35] In this study, we report that Vitamin D upregulates LC3B expression. Previous study identified a conserved LC3-interacting region in mitogen-activated protein kinase 15 (MAPK15). [36] These data suggest that Vitamin D could induced LC3 activation through MAPK pathway. Although LC3 has several homologs, cytosol LC3B is most commonly used for autophagy marker. This is because LC3-II is present on autophagosome membranes, with the former being degraded. [37] We demonstrate that Vitamin D enhances caspase-3 expression in murine model of TB. TNF-alpha promotes caspase activation. [38] It is possible that the interaction of TNF-alpha and calcitriol on mitochondria induces caspase-dependent apoptosis. The results of this study complete the data of other researchers which show that Vitamin D heightens apoptosis by increasing the activity of nitric oxide synthase. The increase of nitric oxide results potential changes in mitochondrial membrane and a release of cytochrome C. [39, 40] 
Supplementation of Vitamin D3 enhances the effectiveness of 2 nd -line anti-tuberculosis therapy by lowering the number of bacteria, expression of pulmonary collagenase enzyme matrix metalloproteinase-1, and cell necrosis
Supplementation of Vitamin D3 enhances the effectiveness of 2 nd -line anti-TB therapy by lowering the number of bacteria. Since 1951, the antimycobacterial Vitamin D has been claimed [41] to inhibit M. tuberculosis growth directly [42] through upregulation of NO and NADPH oxidase, to induce maturation and activation of macrophages, [43] to increase fusion of phagolisosomes [44] and cathelicidin. [45] Together with the Vitamin A, it reduces the transcription of tryptophan-aspartate-containing coat protein. [46] The vitamin minimizes mycobacterium nutrition by inhibiting peroxisome proliferator-activated receptor γ which is responsible for differentiating macrophages into foam cells. [47] Oxidative stress and tuberculosis are closely related. Oxidative stress is also implicated in activation of MMP1. Vitamin D is a secosteroid, an immunosuppressive steroid, the anti-inflammatory effect arising from immune suppression. The protective effect was associated with the induction of endogenous antioxidant and decrease of lipid peroxidation. [48] During treatment of pulmonary TB, we demonstrated that Vitamin D3 significantly inhibited MMP1 expression. Indeed, administration of Vitamin D also lowers MMP7, MMP9, increases TIMP, [49] and lowers granzyme A which hydrolyzes type IV collagen. [50] Large level of reactive oxygen species and oxidative stress will induce cell death through necrotic pathway. The exacerbation of necrotic cell death and collagen destruction are a critical role causing caseous necrosis. [51] Structural equation modeling is used to analyze the relationship between Vitamin D supplementation and necrotic cell death. There is an association between Vitamin D supplementation, autophagy, MMP1 expression, and necrotic cell death. Vitamin D-induced autophagy helps control massive tissue damage by pulmonary collagenase. Adjunctive Vitamin D therapeutic approaches aimed at decreasing necrosis and improving diseases outcomes.
The structural relationship between apoptosis and necrosis is also confirmed. Apoptosis lowers RIPK3 by decreasing the number of bacteria. Apoptosis itself is not intrinsically bactericidal but requires phagocytic uptake of the apoptotic body. Necrosis is not dependent on bacterial virulence. [52] Necrosis was associated with the bacterial load. Necrosis occurs when there is a high-intracellular bacillary load. 
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